Literature DB >> 12869359

Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients.

Margareta Emtner1, Janos Porszasz, Mary Burns, Attila Somfay, Richard Casaburi.   

Abstract

Supplemental oxygen improves exercise tolerance of normoxemic and hypoxemic chronic obstructive pulmonary disease (COPD) patients. We determined whether nonhypoxemic COPD patients undergoing exercise training while breathing supplemental oxygen achieve higher intensity and therefore improve exercise capacity more than patients breathing air. A double-blinded trial was performed involving 29 nonhypoxemic patients (67 years, exercise SaO2 > 88%) with COPD (FEV1 = 36% predicted). All exercised on cycle ergometers for 45 minutes, 3 times per week for 7 weeks at high-intensity targets. During exercise, they received oxygen (3 L/minute) (n = 14) or compressed air (3 L/minute) (n = 15). Both groups had a higher exercise tolerance after training and when breathing oxygen. However, the oxygen-trained group increased the training work rate more rapidly than the air-trained group. The mean +/- SD work rate during the last week was 62 +/- 19 W (oxygen-trained group) and 52 +/- 22 W (air-trained group) (p < 0.01). After training, endurance in constant work rate tests increased more in the oxygen-trained group (14.5 minutes) than in the air-trained group (10.5 minutes) (p < 0.05). At isotime, the breathing rate decreased four breaths per minute in the oxygen-trained group and one breath per minute in the air-trained group (p = 0.001). We conclude that supplemental oxygen provided during high-intensity training yields higher training intensity and evidence of gains in exercise tolerance in laboratory testing.

Entities:  

Mesh:

Year:  2003        PMID: 12869359     DOI: 10.1164/rccm.200212-1525OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  43 in total

1.  Physiotherapy practice and delegation policies in oxygen administration: a survey of ontario hospitals.

Authors:  Olivia Espiritu; Erin Schaeffer; Natasha Bhesania; Sarah Perera; Emma Dickinson; Ethne Nussbaum; Denise Lai
Journal:  Physiother Can       Date:  2009-07-16       Impact factor: 1.037

2.  Combination therapy for exercise intolerance in COPD.

Authors:  R Casaburi
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

3.  Physiological responses to interval endurance exercise at different levels of blood flow restriction.

Authors:  Rogério B Corvino; Harry B Rossiter; Thiago Loch; Jéssica C Martins; Fabrizio Caputo
Journal:  Eur J Appl Physiol       Date:  2016-11-08       Impact factor: 3.078

4.  Use of supplemental oxygen during exercise testing and training for people with chronic obstructive pulmonary disease: a survey of Australian pulmonary rehabilitation programs.

Authors:  Regina W M Leung; Jennifer A Alison; Sue C Jenkins; Anne E Holland; Kylie Hill; Norman R Morris; Lissa M Spencer; Catherine J Hill; Annemarie L Lee; Helen E Seale; Nola M Cecins; Christine F McDonald; Zoe J McKeough
Journal:  Braz J Phys Ther       Date:  2020-05-15       Impact factor: 3.377

5.  Long-Term Oxygen Therapy.

Authors:  Andreas Rembert Koczulla; Tessa Schneeberger; Inga Jarosch; Klaus Kenn; Rainer Gloeckl
Journal:  Dtsch Arztebl Int       Date:  2018-12-24       Impact factor: 5.594

6.  Effects of a Highly Portable Noninvasive Open Ventilation System on Activities of Daily Living in Patients with COPD.

Authors:  Brian W Carlin; Kimberly S Wiles; Robert W McCoy; Toni Brennan; Dan Easley; Richard J Thomashow
Journal:  Chronic Obstr Pulm Dis       Date:  2015-01-01

7.  Ambulatory Oxygen for Exercise-Induced Desaturation and Dyspnea in Chronic Obstructive Pulmonary Disease (COPD): Systematic Review and Meta-Analysis.

Authors:  Stanley I Ejiofor; Susan Bayliss; Abubacarr Gassamma; Alice M Turner
Journal:  Chronic Obstr Pulm Dis       Date:  2016-01-06

Review 8.  ERS International Congress 2017: a peek of outstanding abstracts from the clinical assembly.

Authors:  Nicolas Kahn; Vasileios Andrianopoulos; Evgeni Mekov; Felix J F Herth
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 9.  Factors contributing to muscle wasting and dysfunction in COPD patients.

Authors:  Rob C I Wüst; Hans Degens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 10.  Is there any treatment other than drugs to alleviate dyspnea in COPD patients?

Authors:  Nicolino Ambrosino; Guido Vagheggini
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.